NEW YORK (GenomeWeb) – CollabRx and Medytox Solutions today said that they have entered into a non-binding letter of intent to negotiate a merger between the firms.

In addition, Medytox is providing CollabRx with a loan so the San Francisco-based bioinformatics firm can continue to operate while the firms negotiate a potential deal.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.